Zimmer Floats Divestments To Win European Approval Of Biomet Acquisition
This article was originally published in The Gray Sheet
Executive Summary
Zimmer is negotiating with the European Commission on a strategic divestment strategy that would allow European anti-trust regulators to approve Zimmer’s pending acquisition of Biomet.